mRNA stability and the control of gene expression: Implications for human disease

Neurochemical Research

Volumn 27, Issue 10, 2002, Pages 957-980

  Hollams, Elysia M ^a   Giles, Keith M ^a   Thomson, Andrew M ^a   Leedman, Peter J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cancer; cis elements; Disease; MRNA decay; MRNA stability; RNA binding proteins

Indexed keywords

PROTIRELIN RECEPTOR; RNA BINDING PROTEIN;

ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CIS TRANS ISOMERISM; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; IRON RESPONSIVE ELEMENT; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA STABILITY; RNA TRANSCRIPTION; STIMULUS RESPONSE;

GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; RNA STABILITY; RNA, MESSENGER;

EID: 0036808553     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020992418511     Document Type: Article

References (339)

1. Shatkin, A. J. and Manley, J. L. 2000. The ends of the affair: Capping and polyadenylation. Nat. Struct. Biol. 7:838-842.
2. Colgan, D. F. and Manley, J. L. 1997. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11:2755-2766.
3. Wahle, E. and Ruegsegger, U. 1999. 3′-End processing of pre-mRNA in eukaryotes. FEMS Microbiol. Rev. 23:277-295.
4. Brawerman, G. 1981. The role of poly(A) sequence in mammalian messenger mRNA. CRC Crit. Rev. Biochem. 10:1-38.
5. Dreyfuss, G., Hentze, M., and Lamond, A. I. 1996. From transcript to protein. Cell 85:963-972.
6. Grabowski, P. J. and Black, D. L. 2001. Alternative RNA splicing in the nervous system. Prog. Neurobiol. 65:289-308.
7. Cole, C. N. 2001. Choreographing mRNA biogenesis. Nat. Genet. 29:6-7.
8. Proudfoot, N. 2000. Connecting transcription to messenger RNA processing. Trends Biochem. Sci. 25:290-293.
9. Siomi, M. C. 2000. The molecular mechanisms of messenger RNA nuclear export. Cell Struct. Funct. 25:227-235.
10. Reed, R. and Magni, K. 2001. A new view of mRNA export: Separating the wheat from the chaff. Nat. Cell Biol. 3:E201-E204.
11. Shimotohno, K., Kodama, Y., Hashimoto, J., and Miura, K.-I. 1977. Importance of 5′-terminal blocking structure to stabilize mRNA in eukaryotic protein synthesis. Proc. Natl. Acad. Sci. USA 5:2734-2738.
12. Drummond, R. D., Armstrong, J., and Colman, A. 1985. The effect of capping and polyadenylation on the stability, movement and translation of synthetic messenger RNAs in Xenopus oocytes. Nucleic Acids Res. 13:7375-7395.
13. Preiss, T. and Hentze, M. W. 1998. Dual function of the messenger RNA cap structure in poly(A)-tail-promoted translation in yeast. Nature 392:516-520.
14. Blobel, G. 1973. A protein of molecular weight 78,000 bound to the polyadenylate region of eukaryotic messenger RNAs. Proc. Natl. Acad. Sci. USA 70:924-928.
15. Baer, B. W. and Kornberg, R. D. 1980. Repeating structure of cytoplasmic poly(A)-ribonucleoprotein. Proc. Natl. Acad. Sci. USA 77:1890-1892.
16. Grange, T., Sa, C. M. d., Oddos, J., and Pictet, R. 1987. Human mRNA polyadenylate binding protein: Evolutionary conservation of a nucleic acid binding motif. Nucleic Acids Res. 15:4771-4787.
17. Sachs, A. B., Bond, M. W., and Kornberg, R. D. 1986. A single gene from yeast for both nuclear and cytoplasmic polyadenylate-binding proteins: Domain structure and expression. Cell 45:827- 835.
18. Burd, C. G. and Dreyfuss, G. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615-621.
19. Burd, C., Matunis, E., and Dreyfuss, G. 1991. The multiple RNA-binding domains of the mRNA poly(A) binding protein have RNA-binding activities. Mol. Cell. Biol. 11:3419-3424.
20. Kuhn, U. and Pieler, T. 1996. Xenopus poly(A) binding protein: Functional domains in RNA binding and protein: Protein interaction. J. Mol. Biol. 256:20-30.
21. Deardorff, J. A. and Sachs, A. B. 1997. Differential effects of aromatic and charged residue substitutions in the RNA binding domains of the yeast poly(A) binding protein. J. Mol. Biol. 269: 67-81.
22. Deo, R. C., Bonanno, J. B., Sonenberg, N., and Burley, S. K. 1999. Recognition of polyadenylate RNA by the poly(A)-binding protein. Cell 98:835-845.
23. Sachs, A. B. and Davis, R. W. 1989. The poly(A) binding protein is required for poly(A) shortening and 60S ribosomal subunit-dependent translation initiation. Cell 58:857-867.
24. Bernstein, P. and Peltz, S. W. 1989. The poly(A)-poly(A) binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9:659-670.
25. Bernstein, P. and Ross, J. 1989. Poly (A), poly (A) binding protein and the regulation of mRNA stability. Trends Biochem. Sci. 14:373-377.
26. Gorlach, M., Burd, C. G., and Dreyfuss, G. 1994. The mRNA poly(A)-binding protein: Localization, abundance and RNA binding specificity. Exp. Cell Res. 211:400-407.
27. Graves, R. A., Pandey, N. B., Chodchoy, N., and Marzluff, W. F. 1987. Translation is required for regulation of histone mRNA degradation. Cell 48:615-626.
28. Gay, D. A., Sisodia, S. S., and Cleveland, D. W. 1989. Auto-regulatory control of β-tubulin mRNA stability is linked to translation elongation. Proc. Natl. Acad. Sci. USA 86:5763-5767.
29. Parker, R. and Jacobson, A. 1990. Translation and a 42- nucleotide segment with in the coding region of the mRNA encoded by the MATα1 gene are involved in promoting rapid mRNA decay in yeast. Proc. Natl. Acad. Sci. USA 87:2780-2784.
30. Aharron, T. and Schneider, R. J. 1993. Selective destabilization of short-lived mRNAs with the granulocyte-macrophage stimulating factor AU-rich 3′ noncoding region is mediated by a cotranlsational mechanism. Mol. Cell. Biol. 13:1971-1980.
31. Winstall, E., Gamache, M., and Raymond, V. 1995. Rapid mRNA degradation mediated by the c-fos AU-rich element and that mediated by the granulocyte-macrophage colony-stimulating factor 3′ AU-rich element occur through similar polysome-associated mechanisms. Mol. Cell. Biol. 15:3796-3804.
32. Curatola, A. M., Nadal, M. S., and Schneider, R. J. 1995. Rapid degradation of AU-rich element (ARE) mRNAs is activated by ribosome transit and blocked by secondary structure at any position 5′ to the ARE. Mol. Cell Biol. 15:6331-6340.
33. Wilson, T. and Treisman, R. 1988. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences. Nature 336:396-399.
34. Gingras, A. C., Raught, B., and Sonenberg, N. 1999. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:913-963.
35. Munroe, D. and Jacobson, A. 1990. mRNA poly(A) tail, a 3′ enhancer of translation initiation. Mol. Cell. Biol. 10:3441-3455.
36. Gallie, D. R. 1991. The cap and poly(A) tail function synergisitcally to regulate mRNA translational efficiency. Genes Dev. 5:2108-2116.
37. Tarun, S. Z. and Sachs, A. B. 1996. Association of the yeast poly(A) tail binding protein with translational initiation factor E1F-4G. EMBO J. 15:7168-7177.
38. Wells, S. E., Hillner, P. E., Vale, R. D., and Sachs, A. B. 1998. Circularization of mRNA by eukaryotic translation initiation factors. Mol. Cell 2:135-40.
39. Craig, A. W. B., Haghighat, A., Yu, A. T. K., and Sonenberg, N. 1998. Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation. Nature 392:520-523.
40. Imataka, H., Gradi, A., and Sonenberg, N. 1998. A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J. 17:7480-7489.
41. Khaleghpour, K., Svitkin, Y. V., Craig, A. W., DeMaria, C. T., Deo, R. C., Burley, S. K., and Sonenberg, N. 2001. Translational repression by a novel partner of human poly(A) binding protein, Paip2. Mol. Cell 7:205-216.
42. Ross, J. and Sullivan, T. D. 1985. Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes. Blood 66:1149-1154.
43. Lekas, P., Tin, K. L., Lee, C., and Prokipcak, R. D. 2000. The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells. Archives of Biochemistry & Biophysics 384:311-318.
44. Shaw, G. and Kamen, R. 1986. A conserved AU sequence form the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
45. Jones, T. and Cole, M. 1987. Rapid cytoplasmic turnover of c-myc mRNA; requirement of the 3′ untranslated sequences. Mol. Cell. Biol. 7:4513-4521.
46. Dani, C., Blanchard, J. M., Piechaczyk, M., Sabouty, S. E., Marty, L., and Jeanteur, P. 1984. Extreme instability of myc mRNA in normal and transformed human cells. Proc. Natl. Acad. Sci. USA 81:7046-7050.
47. Loflin, P. T., Chen, C.-Y. A., Xu, N., and Shyu, A.-B. 1999. Transcriptional pulsing approaches for analysis of mRNA turnover in mammalian cells. Methods 17:11-20.
48. Ross, J. 1999. Assays for analyzing exonucleases in vitro. Methods 17:52-59.
49. Wilson, G. M. and Brewer, G. 1999. Identification and characterization of proteins binding A + U rich elements. Methods 17:74-83.
50. Salles, F. J., Richards, W. G., and Strickland, S. 1999. Assaying the polyadenylation state of mRNAs. Methods 17:38-45.
51. Zhang, S., Williams, C. J., Wormington, M., Stevens, A., and Peltz, S. W. 1999. Monitoring mRNA decapping activity. Methods 17:46-51.
52. Levy, A. P., Levy, N. S., and Goldberg, M. A. 1996. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271:2746-2753.
53. Iwai, Y., Bickel, M., Pluznik, D. H., and Cohen, R. B. 1991. Identification of sequences within the murine granulocyte- macrophage colony-stimulating factor mRNA 3′-untranslated region that mediate mRNA stabilization induced by mitogen treatment of EL-4 thymoma cells. J. Biol. Chem. 266:17959-17965.
54. Brewer, G. 2000. Regulation of c-myc mRNA decay in vitro by a phorbol ester-inducible, ribosome-associated component in differentiating megakaryoblasts. J. Biol. Chem. 275:33336- 33345.
55. Jinno, Y., Merlino, G. T., and Pastan, I. 1988. A novel effect of EGF on mRNA stability. Nucleic Acids Res. 16:4957-4966.
56. McCulloch, R. K., Walker, C. E., Chakera, A., Jazayeri, J., and Leedman, P. J. 1998. Regulation of EGF-receptor expression by EGF and TGF alpha in epidernoid cancer cells is cell type-specific. Int. J. Biochem. Cell Biol. 30:1265-1278.
57. Balmer, L. A., Beveridge, D. J., Jazayeri, J. A., Thomson, A. M., Walker, C. E., and Leedman, P. J. 2001. Identification of a novel AU-Rich element in the 3′ untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins. Mol. Cell Biol. 21:2070-2084.
58. Staton, J. S. and Leedman, P. J. 1998. Posttranscriptional regulation of thyrotropin β-subunit messenger ribonucleic acid by thyroid hormone in murine thyrotrope tumor cells: A conserved mechanism across species. Endocrinology 139:1093-1100.
59. Yeap, B. B., Krueger, R. G., and Leedman, P. J. 1999. Post- transcriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 140:3182-3291.
60. Heaton, J. H., Tillman-Bogush, M., Leff, N. S., and Gelehrter, T. D. 1998. Cyclic nucleotide regulation of plasminogen activator-inhibitor mRNA stability in rat hepatoma cells. J. Biol. Chem. 275:14261-14268.
61. Staton, J. M., Thomson, A. M., and Leedman, P. J. 2000. Hormonal regulation of mRNA stability and RNA-protein interactions in the pituitary. J. Mol. Endocrinol. 25:17-34.
62. Guhaniyogi, J. and Brewer, G. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
63. Brewer, G. and Ross, J. 1988. Poly(A) shortening and degradation of the 3′ AU rich sequences of human c-myc mRNA in a cell free system. Mol. Cell. Biol. 8:1697-1708.
64. Laird-Offringa, I. A., DeWitt, C. L., Elfferich, P., and VanderEb, A. J. 1990. Poly(A) tail shortening is the translation-dependent step in c-myc mRNA degradation. Mol. Cell. Biol. 10:6132-6140.
65. Shyu, A.-B., Belasco, J. G., and Greenberg, M. E. 1991. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5:221-231.
66. Muhlrad, D. and Parker, R. 1992. Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev. 6:2100-2111.
67. Decker, C. J. and Parker, R. 1993. A turnover pathway for both stable and unstable mRNAs in yeast: Evidence for a requirement for deadenylation. Genes Dev. 7:1632-1643.
68. Muhlrad, D., Decker, C. J., and Parker, R. 1994. Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5′→3′ digestion of the transcript. Genes and Devlopment 8:855-866.
69. Lagnado, C. A., Brown, C. Y., and Goodall, G. J. 1994. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14:7984-7995.
70. Chen, C.-Y. A., Chen, T.-M., and Shyu, A.-B. 1994. Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA destabilizing function. Mol. Cell. Biol. 14:416-426.
71. Chen, C.-Y. A., Xu, N. H., and Shyu, A. B. 1995. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol. Cell. Biol. 15:5777-5778.
72. Wang, Z. R. and Kiledjian, M. 2001. Functional link between the mammalian exosome and mRNA decapping. Cell 107:751-762.
73. Ford, L. P., Bagga, P. S., and Wilusz, J. 1997. The poly(A) tail inhibits the assembly of a 3′-to-5′ exonuclease in an in vitro RNA stability system. Mol. Cell. Biol. 17:398-406.
74. Brewer, G. 1998. Characterization of c-myc 3′ to 5′ mRNA decay activities in an in vitro system. J. Biol. Chem. 273:34770-34774.
75. Mukherjee, D., Gao, M., O'Connor, J. P., Raijmakers, R., Pruijn, G., Lutz, C. S., and Wilusz, J. R. 2002. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J. 21:165-174.
76. Korner, C. G. and Wahle, E. 1997. Poly(A) tail shortening by a mammalian poly(A)-specific 3′-exoribonuclease. J. Biol. Chem. 272:10448-10456.
77. Korner, C. G. 1998. The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J. 17:5427-5437.
78. Buiting, K. 1999. The human gene for the poly(A)-specific ribonuclease PARN maps to 16p13 and has a truncated copy in the Prader-Willi/Angelmann syndrome region on 15q11-q13. Cytogenet. Cell Genet. 87:125-131.
79. Dehlin, E., Wormington, M., Korner, C. G., and Wahle, E. 2000. Cap-dependent deadenylation of mRNA. EMBO J. 19:1079-1086.
80. Gao, M., Wilusz, C. J., Peltz, S. W., and Wilusz, J. 2001. A novel mRNA-decapping activity in HeLa cytoplasmic extracts is regulated by AU-rich elements. EMBO J. 20:1134-1143.
81. Martinez, J., Ren, Y. G., Nilsson, P., Ehrenberg, M., and Virtanen, A. 2001. The mRNA cap structure stimulates rate of poly(A) removal and amplifies processivity of degradation. J. Biol. Chem. 276:27923-27929.
82. Tharun, S. and Parker, R. 2001. Targeting an mRNA for decapping: Displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol. Cell 8:1075-1083.
83. Mitchell, P. 1997. The 3′ end of yeast 5.8S rRNA is generated by an exonuclease processing mechanism. Genes Dev. 10:502-513.
84. Mian, I. S. 1997. Comparative sequence analysis of ribonucleases HII, III, II, PH and D. Nucleic Acids Res. 25:3187-3195.
85. Mitchell, P., Petfalski, E., Shevchenko, A., Mann, M., and Tollervey, D. 1997. The exosome: A conserved eukaryotic RNA processing complex containing multiple 3′-5′ exoribonucleases. Cell 91:457-466.
86. Zanchin, N. I. T. and Goldfarb, D. S. 1999. The exosome subunit Rrp43p is required for the efficient maturation of 5.8S, 18S and 25S rRNA. Nucleic Acids Res. 27:1283-1288.
87. Allmang, C., Mitchell, P., Petfalski, E., and Tollervey, D. 2000. Degradation of ribosomal RNA precursors by the exosome. Nucleic Acids Res. 28:1684-1691.
88. de la Cruz, J., Kressler, D., Tollervey, D., and Linder, P. 1998. Dob1p (mtr4p) is a putative atp-dependent rna helicase required for the 3′ end formation of 5.8s rrna in saccharomyces cerevisiae. EMBO J. 17:1128-1140.
89. Briggs, M. W., Burkard, K. T., and Butler, J. S. 1998. Rrp6p, the yeast homologue of the human PM-Scl 100-kDa autoantigen is essential for efficient 5.8sS rRNA 3′ end formation. J. Biol. Chem. 273:13255-13263.
90. Van Hoof, A., Lennertz, P., and Parker, R. 2000. Yeast exosome mutants accumulate 3′-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs. Mol. Cell Biol. 20:441-452.
91. Allmang, C., Kufel, J., Chanfreau, G., Mitchell, P., Petfalski, E., and Tollervey, D. 1999. Functions of the exosome in rRNA, snoRNA and snRNA synthesis. EMBO J. 18:5399-5410.
92. Chen, C. Y., Gherzi, R., Ong, S. E., Chan, E. L., Raijmakers, R., Pruijn, G. J. M., Stoecklin, G., Moroni, C., Mann, M., and Karin, M. 2001. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107:451-464.
93. Butler, J. S. 2002. The yin and yang of the exosome. Trends Cell. Biol. 12:90-96.
94. van Hoof, A. and Parker, R. 1999. The exosome: A proteosome for RNA? Cell 99:347-350.
95. Estevez, A. M., Kempf, T., and Clayton, C. 2001. The exosome of Trypanosoma brucei. EMBO J. 20:3831-3839.
96. Chekanova, J. A., Shaw, R. J., Wills, M. A., and Belostotsky, D. A. 2000. Poly(A) tail-dependent exonuclease AtRrp41p from Arabidopsis thaliana rescues 5.8 SrRNA processing and fnRNA decay defects of the yeast ski6 mutant and is found in an exosome-sized complex in plant and yeast cells. J. Biol. Chem. 275:33158-33166.
97. Chekanova, J. A., Dutko, J. A., Mian, I. S., and Belostotsky, D. A. 2002. Arabidopsis thaliana exosome subunit AtRrp4p is a hydrolytic 3′→5′ exonuclease containing SI and KH RNA-binding domains. Nucleic Acids Res. 30:695-700.
98. Meinsma, D., Scheper, W., Hlothuizen, P. E., vandenBrande, J. L., and Sussenbrach, J. S. 1992. Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene. Nucleic Acids Res. 20:5003-5009.
99. Binder, R., Horowitz. J. A., Balison, J. P., Koeller, D. M., Klausner, R. D., and Harford, J. B. 1994. Evidence that the pathway of degradation of transferrin receptor involves an endonucleolytic cleavage within the 3′ UTR and does not involve poly (A) tail shortening. EMBO J. 13:1969-1980.
100. Stoeckle, M. Y. 1991. Post-transcriptional regulation of groα,β,γ and IL-8 mRNAs by IL-1β. Nucleic Acids Res. 19:917-920.
101. Stoeckle, M. Y. 1992. Removal of a 3′ non-coding sequence is an initial step in degradation of groα mRNA and is regulated by interleukin-1. Nucleic Acids Res. 20:1123-1127.
102. Binder, R., Hwang, S. P., Ratnasbapathy, R., and Williams, D. L. 1989. Degradation of apolipoprotein II mRNA via endonucleolytic cleavage at 5′-AAU-3′/5′-UAA-3′ elements in single stranded loop domains at the 3′ noncoding region. J. Biol. Chem. 264:16910-16918.
103. Stoeckle, M. Y. and Hanafusa, H. 1989. Processing of 9E3 mRNA and regulation of its stability in normal and Rous sarcoma virus-transformed cells. Mol. Cell. Biol. 9:4738-4745.
104. Brown, B. D. and Harland, R. M. 1990. Endonucleolytic cleavage of a maternal homeobox mRNA in Xenopus oocytes. Genes Dev. 4:1925-1935.
105. Brown, B. D., Zipkin, 1. D., and Harland, R. M. 1993. Sequence-specific endonucleolytic cleavage and protection of mRNA in Xenopus and Drosophila. Genes Dev. 7:1620-1631.
106. Pastori, R. L. and Schoenberg, D. R. 1993. The nuclease that specifically degrades albumin mRNA in vitro associates with Xenopus liver through the 80s ribosome complex. Arch. Biochem. Biophys. 305:313-319.
107. Rodgers, N. D., Wang, Z., and Kiledjian, M. 2002. Characterization and purification of a mammalian endoribonuclease specific for the α-globin mRNA. J. Biol. Chem. 277:2597-2604.
108. Bernstein, P. L., Herrick, D. J., Prokipcak, R. D., and Ross, J. 1992. Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant, Genes Dev. 6:642-654.
109. Zhao, Z., Chang, F. C., and Furneaux, H. M. 2000. The identification of an endonuclease that cleaves within an HuR binding site in mRNA. Nucleic Acids Res. 28:2695-2701.
110. Nielsen, F. C. and Christiansen, J. 1992. Endonucleosis in the turnover of insulin-like growth factor II mRNA. J. Biol. Chem. 267:19404-19411.
111. Le Hir, H., Izaurralde, E., Maquat, L. E., and Moore, M. J. 2000. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 19:6860-6869.
112. Nagy, E. and Macquat, L. E. 1998. A rule for termination- codon position within intron-containing genes: When nonsense affects RNA abundance. Trends in Biochemical Science 23: 198-199.
113. Gonzalez, C. I., Bhattacharya, A., Wang, W. R., and Peltz, S. W. 2001. Nonsense-mediated mRNA decay in Saccharomyces cerevisiae. Gene 274:15-25.
114. Byers, P. H. 2002. Killing the messenger: New insights into nonsense- mediated mRNA decay. J. Clin. Invest. 109:3-6.
115. Chen, C.-Y. A. and Shyu, A.-B. 1994. Selective degradation of early-response-gene mRNAs: Functional analyses of sequence features of the AU-rich elements. Mol. Cell. Biol. 14:8471-8482.
116. Narayanan, C. S., Fujimoto, J., Geras-Raaka, E., and Gershengorn, M. C. 1992. Regulation by thyrotropin-releasing hormone (TRH) of TRH receptor mRNA degradation in rat pituitary GH3 cell. J. Biol. Chem. 267:17296-17303.
117. Fujimoto, J., Narayanan, C. S., Benjamin, J. E., and Gershengorn, M. C. 1992. Posttranscriptional Up-regulation of Thyrotropin-releasing Hormone (TRH) Receptor Messenger Ribonucleic Acid by TRH in COS-1 Cells Transfected with Mouse Pituitary TRH Receptor Complementary Deoxyribonucleic Acid. 131: 1716-1720.
118. Fujimoto, J., Narayanan, C. S., Benjamin, J. E., Heinflink, M., and Gershengorn, M. C. 1992. Mechanism of regulation of thyrotropin-releasing hormone receptor messenger ribonucleic acid in stably transfected rat pituitary cells. Endocrinology 130:1879-1884.
119. Mullner, E. W. and Kuhn, L. C. 1988. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53:815-825.
120. Koeller, D. M., Casey, J. L., Hentze, M. W., Gerhardt, E. M., Chan, L. N., Klausner, R. D., and Harford, J. B. 1989. A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA. Proc. Natl. Acad. Sci. USA 86:3574-3578.
121. Pandey, N. B. and Marzluff, W. F. 1987. The stem-loop structure at the 3′ end of histone mRNA is necessary and sufficient for regulation of histone mRNA stability. Mol. Cell Biol. 7:4557-4559.
122. Pandey, A. B., Sun, J.-H., and Mazluff, W. F. 1991. Different mRNA complexes are fromed on the 3′ end of histone mRNA with nuclear and polyribosomal proteins. Nucleic Acids Res. 19:5653-5659.
123. Wang, X., Kiledjian, M., Weiss, I. M., and Liebhaber, S. A. 1995. Detection and characterization of a 3′ untranslated region ribonucleoprotein complex associated with human α-globin mRNA. Mol. Cell. Biol. 15:1769-1777.
124. Brown, C. Y., Lagnado, C. A., and Goodall, G. J. 1996. A cytokine mRNA-destabilizing element that is structurally and functionally distinct from A+U-rich elements. Proc. Natl. Acad. Sci. USA 93:13721-13725.
125. Gillis, P. and Malter, J. S. 1991. The adenosine-uridine binding factor recognises the AU-rich elements of cytokine, lymphokine and oncogene mRNAs. J. Biol. Chem. 266:3172-3177.
126. Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., and Cerami, A. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670-1674.
127. Kontoyiannis, D., Pasparikis, M., Pizarro, T. T., Cominelli, F., and Kollias, G. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity 10:387-398.
128. Levy, A. P., Levy, N. S., and Goldberg, M. A. 1996. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von hippel lindau protein. J. Biol. Chem. 271:25492-25497.
129. Meijlink, F., Curran, T., Miller, A. D., and Verma, I. M. 1985. Removal of a 67-base pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene. Proc. Natl. Acad. Sci. USA 82:4987-4991.
130. Raymond, V., Atwater, J. A., and Verma, I. M. 1989. Removal of an mRNA destqabilizing element correlates with the increased oncogenicity of proto-oncogene fos. Oncogene Res. 5:1-12.
131. Chen, C.-Y. A. and Shyu, A.-B. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
132. Zubiaga, A. M., Belasco, J. G., and Greenberg, M. E. 1995. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15:2219-2230.
133. Kabnick, K. S. and Housman, D. E. 1988. Determinants that contribute to cytoplasmic stability of human c-fos and β-globin mRNAs are located at several sites in each mRNA. Mol. Cell. Biol. 8:3244-3250.
134. Bakheet, 2001. ARED: human AU-rich element-containiong mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 29:246-254.
135. Pesole, G., Mignone, F., Gissi, C., Grillo, G., Licciulli, F., and Liuni, S. 2001. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276:73-81.
136. Laroia, G., Sarkar, B., and Schneider, R. J. 2002. Ubiquitin-dependent mechanism regulates rapid turnover of AU-rich cytokine mRNAs. Proc. Natl. Acad. Sci. USA 99:1842-1846.
137. Wilkinson, K. D. 2000. Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11:141-148.
138. Theil, E. C. 1998. The iron responsive element (IRE) family of mRNA regulators. Regulation of iron transport and uptake compared in animals, plants, and microorganisms. Met. Ions Biol. Syst. 35:403-434.
139. Addess, K. J., Basilion, J. P., Klausner, R. D., Rouault, T. A., and Pardi, A. 1997. Structure and dynamics of the iron responsive element RNA-implications for binding of the RNA by iron regulatory binding proteins. J. Mol. Biol. 274:72-83.
140. Thomson, A. M., Rogers, J. T., and Leedman, P. J. 1999. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int. J. Biochem. Cell Biol. 31:1139-1152.
141. Kuhn, L. C., Sculman, H. M., and Ponka, P. 1990. Iron transferring requirements and transferrin receptor expression in proliferating cells. Pages 149-191, in Ponka, P., Sculman, H. M., and Woodworth, R. C. (eds). Iron Transport and Storage, CRC, Boca Raton, FL.
142. Richardson, D. R. and Ponka, P. 1997. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim. Biophys. Acta 1331:1-40.
143. Leibold, E. A. and Guo, B. 1992. Iron-dependent regulation of ferritin and transferrin receptor expression by iron responsive element binding protein. Annu. Rev. Nutr. 12:345-368.
144. Klausner, R. D., Rouault, T. A., and Harford, J. B. 1993. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 72:19-28.
145. Rouault, T. A. and Klausner, R. D. 1996. Post-transcriptional regulation of genes of iron metabolism in mammalian cells. J. Biol. Inorg. Chem. 1:494-499.
146. Fleming, M. D., Trenor, C. C., Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., and Andrews, N. C. 1997. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16:383-386.
147. Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F. B., Nussberger, W. F., S., Gollan, J. L., and Hediger, M. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482-488.
148. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., Law, T. C., Brugnara, C., Lux, S. E., Pinkus, G. S., Pinkus, J. L., Kingsley, P. D., Palis, J., Fleming, M. D., Andrews, N. C., and Zon, L. I. 2000. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403:776-781.
149. McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., Hediger, M. A., Hentze, M. W., and Simpson, R. J. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5:299-309.
150. Theil, E. C. and Eisenstein, R. S. 2000. Combinatorial mRNA regulation: Iron regulatory proteins and iso-iron-responsive elements (Iso-IREs). J. Biol. Chem. 275:40659-40662.
151. Ke, Y., Wu, J., Leibold, E. A., Walden, W. E., and Theil, E. C. 1998. Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation? J. Biol. Chem. 273:23637-23640.
152. Ponka, P. 1999. Cellular iron metabolism. Kidney Int. Suppl. 69: S2-S 11.
153. Ponka, P. and Lok, C. N. 1999. The transferrin receptor: Rote in health and disease. Int. J. Biochem. Cell Biol. 31:1111- 1137.
154. Sachs, A. B., Sarnow, P., and Hentze, M. W. 1997. Starting at the beginning, middle, and end: Translation initiation in eukaryotes. Cell 89:831-838.
155. Muckenthaler, M., Gray, N. K., and Hentze, M. W. 1998. IRP- 1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex eIF4F. Mol. Cell 2:383-388.
156. Thomson, A. M., Rogers, J. T., and Leedman, P. J. 2000. Thyrotropin-releasing hormone and epidermal growth factor regulate iron-regulatory protein binding in pituitary cells via protein kinase C-dependent and -independent signaling pathways. J. Biol. Chem. 275:31609-31605.
157. de la Pena, P., Delgado, L. M., del Camino, D., and Barros, F. 1992. Cloning and expression of the thyrotropin-releasing hormone receptor from GH3 rat anterior pituitary cells. Biochem. J. 284:891-899.
158. de la Pena, P., Delgado, L. M., del Camino, D., and Barros, F. 1992. Two isoforms of the thyrotropin-releasing hormone receptor generated by alternative splicing have indistinguishable functional properties. J. Biol. Chem. 267:25703-25708.
159. Duthie, S. M., Taylor, P. L., Anderson, L., Cook, J., and Eidne, K. A. 1993. Cloning and functional characterisation of the human TRH receptor. Mol. Cell Endocrinol. 95:R11-R15.
160. Cao, J., O'Donnell, D., Vu, H., Payza, K., Pou, C., Godbout, C., Jakob, A., Pelletier, M., Lembo, P., Ahmad, S., and Walker, P. 1998. Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor. J. Biol. Chem. 273:32281-32287.
161. Straub, R. E., Frech, G. C., Joho, R. H., and Gershengorn, M. C. 1990. Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. Proc. Natl. Acad. Sci. USA 87:9514-9518.
162. Heuer, H., Schafer, M. K., O'Donnell, D., and Walker, P. 2000. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J. Comp. Neurol. 428:319-336.
163. Dreyfuss, G., Kim, V. N., and Kataoka, N. 2002. Messenger-RNA binding proteins and the messages they carry. Nat. Revs. Mol. Cell Biol. 3:195-205.
164. Fan, X. C. and Steitz, J. A. 1998. HNS, a nuclear- cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. USA 95: 15293-15928.
165. Leedman, P. I., Stein, A. R., and Chin, W. W. 1995. Regulated specific protein binding to a conserved region of the 3′-untranslated region of thyrotropin beta-subunit mrna. Mol. Endocrinol. 9:375-387.
166. Thomson, A. M., Rogers, J. T., Walker, C. E., Staton, J. M., and Leedman, P. J. 1999. Optimized RNA gel-shift and UV cross-linking assays for characterization of cytoplasmic RNA- protein interactions. BioTechniques 27:1032-1042.
167. Wang, W., Furneaux, H., Caldwell, M. C., Hutter, D., Liu, Y., Holbrook, N., and Gorospe, M. 2000. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell. Biol. 20:760-769.
168. Wang, W., Caldwell, M. C., Lin, S., Furneaux, H., and Gorospe, M. 2000. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J. 19:2340-2350.
169. Musco, G., Stier, G., Joseph, C., Castiglione Morelli, M. A., Nilges, M., Gibson, T. J., and Pastore, A. 1996. Three-dimensional structure and stability of the KH domain: Molecular insights into the fragile X syndrome. Cell 85:237-245.
170. St. Johnston, D., Brown, N. H., Gall, J. G., and Jantsch, M. 1992. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA 89:10979-10983.
171. Nanduri, S., Carpick, B. W., Yang, Y., Williams, B. R., and Qin, J. 1998. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17:5458-5465.
172. Malter, J. S. 1989. Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664-666.
173. Brewer, G. 1991. An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11: 2460-2466.
174. Bohjanen, P. R., Petryniak, B., June, C. H., Thompson, C. B., and Lindsten, T. 1991. An inducible cytoplasmic factor (AUB) binds selectivity to AUUUA multimers in the 3′ UTR of lymphokine mRNA. Mol. Cell. Biol. 11:3288-3295.
175. Bohjanen, P. R., Petryniak, B., June, C. H., Thompson, C. B., and Lindsten, T. 1992. AU RNA-binding factors differ in their binding specificities and affinities. J. Biol. Chem. 267:6302- 6309.
176. Levine, T. D., Gao, F., King, P. H., Andrews, L. G., and Keene, J. D. 1993. Hel-N1: An autoimmune RNA-binding protein with specificity for 3′ uriylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13:3494-3504.
177. Hamilton, B. J., Nagy, E., Malter, J. S., Arrick, B. A., and Rigby, W. F. 1993. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J. Biol. Chem. 268:8881-8887.
178. Myer, V. E. and Steitz, J. A. 1995. Isolation and characterization of
179. Nakagawa, J., Waldner, H., Meyermonard, S., Hofsteenge, J., Jeno, P., and Moroni, C. 1995. AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc. Natl. Acad. Sci. USA 92:2051-2055.
180. Nagy, E. and Rigby, W. F. 1995. Glyceraldehyde-3 -phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)- binding region (Rossmann fold). J. Biol. Chem. 270:2755-2763.
181. Ma, W. J., Cheng, S., Campbell, C., Wright, A., and Furneaux, H. 1996. Cloning and characterization of HuR, a ubiquitously expressed ELAV-like protein. J. Biol. Chem. 271:8144-8151.
182. Myer, V. E., Fan, X. H. C., and Steitz, J. A. 1997. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16:2130-2139.
183. Chung, S., Jiang, L., Cheng, S., and Furneaux, H. 1996. Purification and properties of HuD, a neuronal RNA-binding protein. J. Biol. Chem. 271:11518-11524.
184. Carballo, E., Lai, W. S., and Blackshear, P. J. 1998. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281:1001-1005.
185. Gueydan, C., Droogmans, L., Chalon, P., Huez, G., Caput, D., and Kruys, V. 1999. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. J. Biol. Chem. 274:2322-2326.
186. Sakai, K., Kitagawa, Y., and Hirose, G. 1999. Analysis of the RNA recognition motifs of human neuronal ELAV-like proteins in binding to a cytokine mRNA. Biochem. Biophys. Res. Commun. 256:263-268.
187. Wilson, G. M., Sutphen, K., Bolikal, S., Chuang, K. Y., and Brewer, G. 2001. Thermodynamics and kinetics of Hsp70 association with A+U-rich mRNA-destabilizing sequences. J. Biol. Chem. 276:44450-44456.
188. Brewer, G. and Ross, I. 1989. Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol. Cell. Biol. 9:1996-2006.
189. Wagner, B. J., Demaria, C. T., Sun, Y., Wilson, G. M., and Brewer, G. 1998. Structure and genomic organization of the human AUF1 gene-alternative pre-mRNA splicing generates four protein isoforms. Genomics 48:195-202.
190. Zhang, W., Wagner, B. J., Ehrenman, K., Schaefer, A. W., DeMaria, C. T., Carter, D., Dehaven, C., Long, L., and Brewer, G. 1993. Purification, characterization, and cDNA cloning of an Au-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13:7652-7665.
191. DeMaria, C. T. and Brewer, G. 1996. AUF1 binding activity to A+U rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271:12179-12184.
192. Wagner, B. J., Long, L., Rao, P. N., Pettenati, M. J., and Brewer, G. 1996. Localization and physical mapping of genes encoding the A+U-rich element RNA-binding protein AUF1 to human chromosomes 4 and X. Genomics 34:219-222.
193. Xu, N.H., Chen, C. Y. A., and Shyu, A. B. 2001. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol. Cell Biol. 21:6960-6971.
194. Grosset, C., Chen, C.-Y., Xu, N., Sonenburg, N., Jacquemin-Sablon, H., and Shyu, A.-B. 2000. A mechanism for translationally coupled mRNA turnover: Interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell. 103:29-40.
195. Pande, A., Tremmel, K. D., Demaria, C. T., Blaxall, B. C., Minobe, W. A., Sherman, J. A., Bisognano, J. D., Bristow, M. R., Brewer, G., and Port, J. D. 1996. Regulation of the mRNA-binding protein AUF1 by activation of the β-adrenergic receptor signal transduction pathway. J. Biol. Chem. 271:8493-8501.
196. Kiledjian, M., DeMaria, C. T., Brewer, G., and Novick, K. 1997. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the α-globin mRNA stability complex. Mol. Cell Biol. 17:4870-4876.
197. Sirenko, O. I., Lofquist, A. K., DeMaria, C. T., Morris, J. S., Brewer, G., and Haskill, J. S. 1997. Adhesion-dependent regulation of an A+U-rich element-binding activity associated with AUF1. Mol. Cell Biol. 17:3898-3906.
198. Wang, X. Y., Hoyle, P. E., and McCubrey, J. A. 1998. Characterization of proteins binding the 3′ regulatory region of the IL-3 gene in IL-3-dependent and autocrine-transformed hematopoietic cells. Leukemia 12:520-531.
199. Pende, A., Giacche, M., Castigliola, L., Contini, L., Passerone, G., Patrone, M., Port, J. D., and Lotti, G. 1999. Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA. Biochem. Biophys. Res. Commun. 266:609-614.
200. Sela-Brown, A., Silver, J., Brewer, G., and Naveh-Many, T. 2000. Identification of AUF1 as a parathyroid hormone mRNA 3′-untranslated region-binding protein that determines parathyroid hormone mRNA stability. J. Biol. Chem. 275:7424-7429.
201. Lin, S. K., Wang, W. G., Wilson, G. M., Yang, X. L., Brewer, G., Holbrook, N. J., and Gorospe, M. 2000. Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol. Cell Biol. 20:7903-7913.
202. Wilson, G. M., Sutphen, K., Chuang, K. Y., and Brewer, G. 2001. Folding of A+U-rich RNA elements modulates AUF1 binding: Protein roles in regulation of mRNA turnover. J. Biol. Chem. 276:8695-8704.
203. Tolnay, M., Barany, L., and Tsokos, G. C. 2000. Heterogeneous nuclear ribonucleoprotein DO contains transactivator and DNA-binding domains. Biochem. J. 348:151-158.
204. Eversole, A. and Maizels, N. 2000. In vitro properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance. Mol. Cell Biol. 20:5425-5432.
205. Dempsey, L. A., Hanakahi, L. A., and Maizels, N. 1998. A specific isoform of hnRNP D interacts with DNA in the LR1 heterodimer: Canonical RNA binding motifs in a sequence-specific duplex DNA binding protein. J. Biol. Chem. 273:29224-29229.
206. Nagata, T., Kurihara, Y., Matsuda, G., Saeki, J., Kohno, T., and Yanagida, Y. 1999. Structure and interaction with RNA of the N-terminal UUAG-specific RNA-binding domain of hnRNP Do. J. Mol. Biol. 287:221-237.
207. Katahira, M., Miyanoiri, Y., Enokizono, Y., Matsuda, G., Nagata, T., Ishikawa, F., and Uesugi, S. 2001. Structure of the C-terminal RNA-binding domain of hnRNP DO (AUF1), its interactions with RNA and DNA, and change in backbone dynamics upon complex formation with DNA. J. Mol. Biol. 311:973-988.
208. DeMaria, C. T., Sun, Y., Long, L., Wagner, B. J., and Brewer, G. 1997. Structural determinants in AUF1 required for high affinity binding to A + U-rich elements. J, Biol. Chem. 272:27635-27643.
209. Wilson, G. M., Sun, Y., Lu, H. P., and Brewer, G. 1999. Assembly of AUF1 oligomers on U-rich RNA targets by sequential dimer association. J. Biol. Chem. 274:33374-33381.
210. Holcik, M. and Liebhaber, S. A. 1997. Four highly stable eukaryotic mRNAs assemble 3′ untranslated region RNA-protein complexes sharing cis and trans components. Proc. Natl. Acad. Sci. USA 94:2410-2414.
211. Chkheidze, A. N., Lyakhov, D. L., Makeyev, A. V., Morales, J., Kong, J., and Liebhaber, S. A. 2001. Assembly of the α-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3′ untranslated region determinant and poly(C) binding αCP. Mol. Cell. Biol. 19:4572-4581.
212. Lai, W. S., Carballo, E., Strum, J. R., Kennington, E. A., Phillips, R. S., and Blackshear, P. J. 1999. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell Biol. 19:4311-4323.
213. Taylor, G. A., Thompson, M. J., Lai, W. S., and Blackshear, P. J. 1996. Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor. Mol. Endocrinol. 10:140-146.
214. Taylor, G. A., Thompson, M. J., Lai, W. S., and Blackshear, P, J. 1995. Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro. J. Biol. Chem. 270:13341-13347.
215. Taylor, G, A., Carballo, E., Lee, D. M., Lai, W. S., Thompson, M. J., Patel, D, D., Schenkman, D, I., Gilkeson, G. S., Broxmeyer, H. E., Haynes, B. F., and Blackshear, P. J. 1996. A pathogenetic role for TNF-alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445-454.
216. Raghavan, A., Robison, R. L., McNabb, J., Miller, C. R., Williams, D. A., and Bohjanen, P. R. 2001. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J. Biol. Chem. 276:47958-47965.
217. Lai, W. S. and Blackshear, P. J. 2001. Interactions of CCCH zinc finger proteins with mRNA-tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J. Biol. Chem. 276:23144-23154.
218. Stoecklin, G., Ming, X. F., Looser, R., and Moroni, C. 2000. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol. Cell Biol. 20:3753-3763.
219. Mahtani, K. R., Brook, M., Dean, J. L. E., Sully, G., Saklatvala, J., and Clark, A. R. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell Biol. 21:6461-6469.
220. Ming, X. F., Stoecklin, G., Lu, M., Looser, R., and Moroni, C. 2001. Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase. Mol. Cell Biol. 21:5778-5789.
221. Zhu, W., Brauchle, M. A., Di Padova, F., Gram, H., New, L., Ono, K., Downey, J. S., and Han, J. H. 2001. Gene suppression by tristetraprolin and release by the p38 pathway. Am. J. Physiol. 281:L499-L508.
222. Johnson, B. A., Geha, M., and Blackwell, T. K. 2000. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 19:1657-1664.
223. Posner, J. B. and Furneaux, H. M. 1990. Paraneoplastic syndromes. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 68:187-219.
224. Darnell, R. B., Furneaux, H. M., and Posner, J. B. 1991. Anti-serum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors. J. Neurosci. 11:1224-1230.
225. Ball, N. S. and King, P. H. 1997. Neuron-specific Hel-N1 and HuD as novel molecular markers of neuroblastoma: A correlation of HuD messenger RNA levels with favorable prognostic features. Clin. Cancer Res. 3:1859-1865.
226. Dalmau, J., Furneaux, H. M., Cordon-Cardo, C., and Posner, J, B. 1992. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol. 141:881-886.
227. Manley, G. T., Smitt, P. S., Dalmau, J., and Posner, J. B. 1995. Hu antigens: Reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann. Neurol. 38:102-110.
228. Dalmau, J., Furneaux, H. M., Rosenblum, M. K., Graus, F., and Posner, J. B. 1991. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuropathy. Neurology 41:1757-1764.
229. Campos, A. R., Grossman, D., and White, K. 1985. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental-genetic analysis. J. Neurogenet. 2:197-218.
230. Robinow, S. and White, K. 1988. The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. Dev. Biol. 126:294-303.
231. Yao, K. M., Samson, M. L., Reeves, R., and White, K. 1993. Gene elav of Drosophila melanogaster: A prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J. Nuerobiol. 24;723-739.
232. Sakai, K., Gofuku, M., Kitagawa, Y., Ogasawara, T., Hirose, G., Yamazaki, M., Koh, C. S., Yanagisawa, N., and Steinman, L. 1994. A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma. Biochem. Biophys. Res. Commun. 199:1200-1208.
233. Szabo, A., Dalmau, J., Manley, G., Rosenfeld, M., Wong, E., Henson, J., Posner, J. B., and Furneaux, H. M. 1991. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67:325-333.
234. Okano, H. J. and Darnell, R. B. 1997. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J. Neurosci. 17:3024-3037.
235. Gao, F. B. and Keene, J. D. 1996. Hel-N1/Hel-N2 proteins are bound to poly(A)+ mRNA in granular RNP structures and are implicated in neuronal differentiation. J. Cell Sci. 109:579-589.
236. Good, P. J. 1997. The role of elav-like genes, a conserved family encoding RNA-binding proteins, in growth and development. Semin. Cell. Dev. Biol. 8:577-584.
237. Liu, J., Dalmau, J., Szabo, A., Rosenfeld, M., Huber, J., and Furneaux, H. 1995. Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology 45:544-550.
238. Chung, S., Eckrich, M., Perrone-Bizzozero, N., Kohn, D. T., and Furneaux, H. 1997. The Elav-like proteins bind to a conserved regulatory element in the 3′-untranslated region of GAP-43 mRNA. J. Biol. Chem. 272:6593-6598.
239. Gao, F. B., Carson, C. C., Levine, T., and Keene, J. D. 1994. Selection of a subset of mRNAs from combinatorial 3′ untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc. Natl. Acad. Sci. USA 91:11207-11211.
240. Antic, D., Lu, N., and Keene, J. D. 1999. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev. 13:449-461.
241. Yeap, B. B., Voon, D. C., Vivian, J. P., McCulloch, R., Thomson, A. M., Giles, K., Czyzyk-Krzeska, M. F., Furneaux, H., Wilce, M. C. J., Wilce, J. A., and Leedman, P. J. 2002. Novel binding of HuR and poly(C) binding protein to a conserved UC-rich motif within the 3′ untranslated region of the androgen receptor. J. Biol. Chem. 277:27183-27192.
242. Jain, R. G., Andrews, L. G., McGowan, K. M., Gao, F., Keene, J. D., and Pekala, P. P. 1995. Hel-N1, an RNA-binding protein, is a ligand for an A + U rich region of the GLUT1 3′ UTR. Nucleic Acids Symp. Ser. 33:209-211.
243. Ma, W. J., Chung, S., and Furneaux, H. 1997. The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA. Nucleic Acids Res. 25:3564-3569.
244. Nabors, L. B., Gillespie, G. Y., Harkins, L., and King, P. H. 2001. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine-and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 61:2154-2161.
245. Levy, N. S., Chung, S., Furneaux, H., and Levy, A. P. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273:6417-6423.
246. Maurer, F., Tierney, M., and Medcalf, R. L. 1999. An AU-rich sequence in the 3′-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucleic Acids Res. 27:1664-1673.
247. Aranda-Abreu, G. E., Behar, L., Chung, S., Furneaux, H., and Ginzburg, I. 1999. Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells. J. Neurosci. 19:6907-6917.
248. Blaxall, B. C., Pellett, A. C., Wu, S. C., Pende, A., and Port, J. D. 2000. Purification and characterization of beta-adrenergic receptor mRNA-binding proteins. J. Biol. Chem. 275:4290-4297.
249. Millard, S. S., Vidal, A., Markus, M., and Koff, A. 2000. A U-rich element in the 5′ untranslated region is necessary for the translation of p27 mRNA. Mol. Cell. Biol. 20:5947-5959.
250. Joseph, B., Orlian, M., and Furneaux, H. 1998. p21(waf1) mRNA contains a conserved element in its 3′-untranslated region that is bound by the Elav-like mRNA-stabilizing proteins. J. Biol. Chem. 273:20511-20516.
251. Haeussler, J., Haeusler, J., Striebel, A. M., Assum, G., Vogel, W., Furneaux, H., and Krone, W. 2000. Tumor antigen HuR binds specifically to one of five protein-binding segments in the 3′-untranslated region of the neurofibromin messenger RNA. Biochem. Biophys. Res. Commun. 267:726-732.
252. Rodriguez-Pascual, F., Hausding, M., Ihrig-Biedert, I., Furneaux, H., Levy, A. P., Forstermann, U., and Kleinert, H. 2000. Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem. 275:26040-26049.
253. Loflin, P. and Lever, J. E. 2001. HuR binds a cyclic nucleotide-dependent, stabilizing domain in the 3′ untranslated region of Na(+)/glucose cotransporter (SGLT1) mRNA. FEBS Lett. 509:267-271.
254. Abe, R., Sakashita, E., Yamamoto, K., and Sakamoto, H. 1996. Two different RNA binding activities for the AU-rich element and the poly(A) sequence of the mouse neuronal protein mHuC. Nucleic Acids Res. 24:4895-4901.
255. Fan, X. C. and Steitz, J. A. 1998. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448-3460.
256. Fan, X. C., Myer, V. E., and Steitz, J. A. 1997. AU-rich elements target small nuclear RNAs as well as mRNAs for rapid degradation. Genes Dev. 11:2557-2568.
257. Peng, S. S., Chen, C. Y., Xu, N., and Shyu, A. B. 1998. RNA stabilization by the AU-rich element binding protein, HuR, and ELAV protein. EMBO J. 17:3461-3470.
258. Gallouzi, I. E., Brennan, C. M., Stenberg, M. G., Swanson, M. S., Eversole, A., Maizels, N., and Steitz, J. A. 2000. HuR binding to cytoplasmic mRNA is perturbed by heat shock. Proc. Natl. Acad. Sci. USA 97:3073-3078.
259. Jain, R. G., Andrews, L. G., McGowan, K. M., Pekala, P. H., and Keene, J. D. 1997. Ectopic expression of Hel-N1, an RNA-binding protein, increases glucose transporter (GLUT1) expression in 3T3-L1 adipocytes. Mol. Cell Biol. 17:954-962.
260. Brennan, C. M., Gallouzi, I. E., and Steitz, J. A. 2000. Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J. Cell Biol. 151:1-14.
261. Keene, J. D. 1999. Why is Hu where? Shuttling of early- response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA 96:5-7.
262. Brennan, C. M. and Steitz, J. A. 2001. HuR and mRNA stability. Cell Mol. Life Sci. 58:266-277.
263. Akamatsu, W., Okano, H. J., Osumi, N., Inoue, T., Nakamura, S., Sakakibara, S., Miura, M., Matsuo, N., Darnell, R. B., and Okano, H. 1999. Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc. Natl. Acad. Sci. USA 96:9885-9890.
264. Kasashima, K., Terashima, K., Yamamoto, K., Sakashita, E., and Sakamoto, H. 1999. Cytoplasmic localization is required for the mammalian ELAV-Iike protein HuD to induce neuronal differentiation. Genes Cells 4:667-683.
265. Wakamatsu, Y. and Weston, J. A. 1997. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 124:3449-3460.
266. Dobashi, Y., Shoji, M., Wakata, Y., and Kameya, T. 1998. Expression of HuD protein is essential for initial phase of neuronal differentiation in rat pheochromocytoma PC12 cells. Biochem. Biophys. Res. Commun. 244:226-229.
267. Quattrone, A., Pascale, A., Nogues, X., Zhao, W., Gusev, P., Pacini, A., and Alkon, D. L. 2001. Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins. Proc. Natl. Acad. Sci. USA 98:11668-11673.
268. Aarts, L. H., Schotman, P., Verhaagen, J., Schrama, L. H., and Gispen, W. H. 1998. The role of the neural growth associated protein B-50/GAP-43 in morphogenesis. Adv. Exp. Med. Biol. 446:85-106.
269. Hentze, M. W. and Kuhn, L. C. 1996. Molecular control of vertebrate iron metabolism-mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc. Natl. Acad. Sci. USA 93:8175-8182.
270. Miller, K., Shipman, M., Trowbridge, I. S., and Hopkins, C. R. 1991. Transferrin receptors promote formation of clathrin lattices. Cell 65:621-631.
271. Andrews, N. C. and Levy, J. 1998. Iron is hot: An update on the pathophysiology of hemachromatosis. Blood 92:1845-1851.
272. de Silva, D. M. and Aust, S. D. 1993. Ferritin and ceruloplasmin in oxidative damage: Review and recent findings. Can. J. Physiol. Pharmacol. 71:715-720.
273. Ponka, P. 1997. Tissue specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells. Blood 89:1-25.
274. Muckenthaler, M., Gunkel, N., Frishman, D., Cyrklaff, A., Tomancak, P., and Hentze, M. W. 1998. Iron-regulatory protein-1 (IRP-1) is highly conserved in two invertebrate species-characterization of IRP-1 homologues in Drosophila melanogaster and Caenorhabditis elegans. Eur. J. Biochem. 254:230-237.
275. Cox, T. C., Bawden, M. J., Martin, A., and May, B. K. 1991. Human erythroid 5-aminolevulinate synthase: Promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J. 10: 1891-1902.
276. Gray, N. K., Pantopoulous, K., Dandekar, T., Ackrell, B. A., and Hentze, M. W. 1996. Translational regulation of mammalian and Drosophila citric acid cycle enzymes via iron-responsive elements. Proc. Natl. Acad. Sci. USA 93:4925-4930.
277. Kohler, S. A., Henderson, B. R., and Kuhn, L. C. 1995. Succinate dehydrogenase b mRNA of Drosophila melanogaster has a functional iron-responsive element in its 5′-untranslate region. J. Biol. Chem. 270:30781-30786.
278. Phillips, J. D., Kinikini, D. V., Yu, Y., Guo, B., and Leibold, E. A. 1996. Differential regulation of IRP1 and IRP2 by nitric oxide in rat hepatoma cells. Blood 87:2983-2992.
279. La Vaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S. K., Miller, G., Abu-Asab, M., Tsokos, M., III, Grinberg, A., Love, P., Tresser, N., and Rouault, T. A. 2001. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:209-214.
280. Konijn, A. M. 1994. Iron metabolism in inflammation. Baillieres Clin. Haematol. 7:829-849.
281. Samaniego, F., Chin, J., Iwai, K., Rouault, T. A., and Klausner, R. D. 1994. Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J. Biol. Chem. 269:30904-30910.
282. Hentze, M. W., Seuanez, H. N., O'Brien, S. J., Harford, J. B., and Klausner, R. D. 1989. Chromosomal localization of nucleic acid-binding proteins by affinity mapping: Assignment of the IRE-binding protein gene to human chromosome 9. Nucleic Acids Res. 17:6103-6108.
283. Rogers, J. T., Bridges, K. R., Durmowicz, G. P., Glass, J., Auron, P. E., and Munro, H. N. 1990. Translational control during the acute phase response: ferritin synthesis in response to interleukin-1. J. Biol. Chem. 265:14572-14578.
284. Beaumont, C., Leneuve, P., Devaux, I., Scoazec, J. Y., Bertier, M., Loiseau, M. N., Grandchamp, B., and Bonneau, D. 1995. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat. Genet. 11:444-446.
285. Rogers, J. T., Andriotakis, J., Lacroix, L., Kasschau K., Durmowicz, G., and Bridges, K. 1994. Translational enhancement of H-ferritin mRNA by interleukin-1 acts through 5′-leader sequences distinct from the iron-responsive element. Nucleic Acids Res. 22:2678-2686.
286. Menotti, E., Henderson, B. R., and Kuhn, L. C. 1998. Translational regulation of mRNAs with distinct IRE sequences by iron regulatory proteins 1 and 2. J. Biol. Chem. 273:1821-1824.
287. Girelli, D., Corrocher, R., Bisceglia, L., Olivieri, O., De Franceschi, L., Zelante, L., and Gasparini, P. 1995. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: A mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood 86:4050-4053.
288. Henderson, B. R., Menotti, E., and Kuhn, L. C. 1996. Iron regulatory proteins 1 and 2 bind distinct sets of RNA target sequences. J. Biol. Chem. 271:4900-4908.
289. Laing, L. G. and Hall, K. B. 1996. A model of the iron responsive element RNA hairpin loop structure determined from NMR and thermodynamic data. Biochemistry 35:13586-13596.
290. Gruer, M. J., Artymiuk, P. J., and Guest, J. R. 1997. The aconitase family: Three structural variations on a common theme. Trends Biochem. Sci. 22:3-6.
291. Schalinske, K. L. and Eisenstein, R. S. 1996. Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells. J. Biol. Chem. 271:7168-7176.
292. Hirling, H., Henderson, B. R., and Kuhn, L. C. 1994. Mutational analysis of the [4Fe-4S]-cluster converting iron-regulatory factor from its RNA-binding form to cytoplasmic aconitase. EMBO J. 13:453-461.
293. Schalinske, K. L., Anderson, S. A., Tuazon. P. T., Chen, O. S., Kennedy, M. C., and Eisenstein, R. S. 1997. The iron-sulfur cluster of iron regulatory protein 1 modulates the accessibility of RNA binding and phosphorylation sites. Biochemistry 36:3950-3958.
294. Kuhn, L. C. 1998. Iron and gene expression: Molecular mechanisms regulating iron homeostasis. Nutr. Rev. 56:S11-S19.
295. Pantopoulos, K. and Hentze, M. W. 1995. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 14:2917-2924.
296. Guo, B., Yu, Y., and Leibold, E. A. 1994. Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity. J. Biol. Chem. 269:24252-24260.
297. Henderson, B. R., Seiser, C., and Kuhn, L. C. 1993. Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements. J. Biol. Chem. 268:27327-27334.
298. Iwai, K., Klausner, R. D., and Rouault, T. A. 1995. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14:5350-5357.
299. Iwai, K., Drake, S. K., Wehr, N. B., Weissman, A. M., La Vaute, T., Minato, N., Klausner, R. D., Devine, R. L., and Rouault, T. A. 1998. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: Implications for degradation of oxidised proteins. Proc. Natl. Acad. Sci. USA 95:4924-4928.
300. Guo, B., Phillips, J. D., Yu, Y., and Leibold, E. A. 1995. Iron regulates the intracellular degradation of iron- regulatory protein 2 by the proteosome. J. Biol. Chem. 270:6103-6108.
301. Schalinske, K. L., Blemings, K. P., Steffen, D. W., Chen, O. S., and Eisenstein, R. S. 1997. Iron regulatory protein 1 is not required for the modulation of ferritin and transferrin receptor expression by iron in a murine pro-B lymphocyte cell line. Proc. Natl. Acad. Sci. USA 94:10681-10686.
302. Czyzyk-Kreska, M. F. and Bendixen, A. C. 1999. Identification of the poly(C) binding protein in the complex associated with the 3′ untranslated region of erythropoietin messenger RNA. Blood 93:2111-2120.
303. Kiledjian, M., Wang, X. M., and Liebhaber, S. A. 1995. Identification of two KH domain proteins in the α-globin mRNP stability complex. EMBO J. 14:4357-4364.
304. Collier, B., Goobar-Larsson, L., Sokolowski, M., and Schwartz, S. 1998. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273:22648-22656.
305. Gamarnik, A. V. and Andino, R. 1997. Two functional complexes formed by KH domain containing protein with the 5′ noncoding region of polio virus RNA. RNA 3:882-892.
306. Ostareck, D. H., Ostareck-lederer, A., Wilm, M., Thiele, B. J., Mann, M., and Hentze, M. W. 1997. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-liopoxygenase translation form the 3′-end. Cell 89: 597-606.
307. Siomi, H., Matunis, M. J., Michael, W. M., and Dreyfuss, G. 1993. The pre-mRNA binding K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res. 21:1193-1198.
308. Preiss, T., Hall, A. G., and Lightowlers, R. N. 1993. Identification of bovine glutamate dehydrogenase as an RNA-binding protein. J. Biol. Chem. 268:24523-24526.
309. Elzinga, S. D., Bednarz, A. L., and van Oosterum, K. 1993. Yeast mitochondrial NAD (+)-dependent isocitrate dehydrogenase is an RNA-binding protein. Nucleic Acids Res. 21:5328-5331.
310. Nagy, E., Henics, T., Eckert, M., Miseta, A., Lightowlers, R. N., and Kellermeyer, M. 2000. Identification of the NAD+- binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain. Biochem. Biophys. Res. Commun. 275:253-260.
311. Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., and Allegra, C. J. 1991. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA 88: 8977-8981.
312. Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., and Zinn, S. 1993. Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro. Biochemistry 32:4756-4760.
313. Clerch, L. B., Wagner, A., and Massaro, D. 1993. FASEB J. 7:A1233.
314. Nanbu, R., Kubo, T., and Natori, S. 1993. Purification of an AU-rich RNA binding protein from Sarcophaga peregrina (flesh fly) and its identification as a thiolase. J. Biochem. 114:432-437.
315. Hollis, G. F., Gazdar, A. F., Bertness, V., and Kirsch, I. R. 1988. Complex translocation disrupts c-myc regulation in a human plasma cell myeloma. Mol. Cell Biol. 8:124-129.
316. Aghib, D. F., Bishop, J. M., Ottolenghi, S., Guerrasio, A., Serra, A., and Saglio, G. 1990. A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. Oncogene 5:707-711.
317. Schuler, G. D. and Cole, M. D. 1988. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumour. Cell 55:1115-1122.
318. Ross, H. J., Sato, N., Ueyama, Y., and Koeffler, H. P. 1991. Cytokine messenger RNA stability is enhanced in tumor cells. Blood 77:1787-1795.
319. Lasa, M., Mahtani, K. R., Finch, A., Brewer, G., Saklatvala, J., and Clark, A. R. 2000. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell Biol. 20:4265-4274.
320. Rimokh, R., Berger, F., Bastard, C., Klein, B., French, M., Archimbaud, E., Rouault, J. P., Santa Lucia, B., Duret, L., and Vuillaume, M. 1994. Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)- associated leukemias. Blood 83:3689-3696.
321. Vassalli, P. 1992. The pathophysiology of tumour necrosis factors. Annu. Rev. Immunol. 10:411-452.
322. Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, H., and Woody, J. N. 1994. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344:1125-1127.
323. Dean, J. L. E., Wait, R., Mahtani, K. R., Sully, G., Clark, A. R., and Saklatvala, J. 2001. The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell Biol. 21:721-730.
324. Di Marco, S., Hel, Z., Lachance, C., Furneaux, H., and Radzioch, D. 2001. Polymorphism in the 3'-untranslated region of TNF alpha mRNA impairs binding of the posttranscriptional regulatory protein HuR to TNF alpha mRNA. Nucleic Acids Res. 29:863-871.
325. Weiss, I. M. and Liebhaber, S. A. 1995. Erythroid cell-specific mRNA stability elements in α-globin 3'untranslated region. Mol. Cell Biol. 15:2457-2465.
326. Morales, L., Russell, J. E., and Liebhaber, S. A. 1997. Destabilization of human alpha-globin mRNA by translation anti-termination is controlled during erythroid differentiation and is paralleled by phased shortening of the poly(A) tail. J. Biol. Chem. 272:6607-6613.
327. Beard, J. L., Connor, J. R., and Jones, B. C. 1993. Iron in the brain. Nutr. Rev. 51:157-170.
328. Loeffler, D. A., Connor, J.R., Juneau, P. L., Snyder, B. S., Kanaley, L., deMaggio, A. J., Nygen, H., Brickamn, C. M., and. LeWitt, P.A. 1995. Transferrin and iron in normal, Alzheimer's disease and Parkinson's disease brain regions. J. Neurochem. 65:710-716.
329. La Vaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S. K., Miller, G., Abu-Asab, M., Tsokos, M., Switzer, R., III, Grinberg, A., Love, P., Tresser, N., and Rouault, T. A. 2001. Targeted deletion of the encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:209-214.
330. Smith, M. A., Wehr, K., Harris, P. L., Siedlak, S. L., Connor, J. R., and Perry, G. 1998. Abnormal localization of iron regulatory protein in Alzheimer's disease. Brain Res. 788:232-236.
331. Pinero, D. J., Hu, J., and Connor, J. R. 2000. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains. Cell Mol. Biol. 46:761-776.
332. Doyle, G. A., Betz, N. A., Leeds, P. F., Fleisig, A. J., Prokipcak, R. D., and Ross, J. 1998. The c-myc coding region determinant-binding protein: A member of a family of KH domain RNA-binding proteins. Nucleic Acids Res. 26:5036-5044.
333. Doyle, G. A., Bourdeau-Heller, J. M., Coulthard, S., Meisner, L. F., and Ross, J. 2000. Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein. Cancer Res. 60:2756-2759.
334. Ross, J., Lemm, I., and Berberet, B. 2001. Overexpression of an mRNA-binding protein in human colorectal cancer. Oncogene 20:6544-6550.
335. Toda. M., Iizuka, Y., Yu, W., Imai, T., Ikeda, E., Yoshida, K., Kawase, T., Kawakami, Y., Okano, H., and Uyemura, K. 2001. Expression of the neural RNA-binding protein Musashil in human gliomas. Glia 34:1-7.
336. Carpentier, A. F., Rosenfeld, M. R., Delattre, J. Y., Whalen, R. G., Posner, J. B., and Dalmau, J. 1998. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clin. Cancer Res. 4:2819-2824.
337. Kennedy, D., Wood, S. A., Ramsdale, T., Tam, P. P., Steiner, K. A., and Mattick, J. S. 1996. Identification of a mouse orthologue of the human ras-GAP-SH3-domain binding protein and structural confirmation that these proteins contain an RNA recognition motif. Biomed. Pept. Proteins Nucleic Acids 2:93-99.
338. Guitard, E., Parker, F., Millon, R., Abecassis, J., and Tocque, B. 2001. G3BP is overexpressed in human tumors and promotes S phase entry. Cancer Lett. 162:213-221.
339. Lu, M., Nakamura, R. M., Dent, E. D., Zhang, J. Y., Nielsen, F. C., Christiansen, J., Chan, E. K., and Tan, E. M. 2001. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am. J. Pathol. 159:945-953.